Dr. Prateet Minhas brings to Eradigm Consulting 15+ years of experience in treating and managing the care of patients. His consulting leadership experience in supporting biopharmaceutical clients to secure market access to therapies at the optimal price across Europe and emerging markets.
As Head of Market Access, Europe and Emerging Markets; Dr. Minhas’s primary focus at Eradigm Consulting is to support biotech clients to secure access at an optimal price.
Prior to joining Eradigm Consulting, Dr. Minhas was a Director at Syneos Health, helping companies with strategic and tactical market access. He has successfully delivered and led 250+ consulting engagements, many of which were focused on pricing, payer value proposition, evidence generation planning, launch planning, and HTA negotiations with country payers. In the last 12 months, Dr. Minhas has supported various clients in HTA negotiations with payers in Brazil, China, Denmark, Finland, Italy, Norway, Spain, and Sweden. The on-hands experience of negotiating with payers and authorities enables Dr. Minhas to provide actionable recommendations to clients and support them in the complete journey from strategy development to actual reimbursement and access to therapies. As a physician, he was responsible for the treatment and day-to-day management of over 300 patients per week and learned key functional skills in healthcare delivery.
Dr. Minhas earned an MBA with merit from Imperial College, London. He is also a trained physician with an MBBS from Maulana Azad Medical College in New Delhi, India.
Outside work, Prateet spends personal time with his wife travelling, Yoga, or cooking. He also has a keen interest in macro and microeconomics and financial markets.